Literature DB >> 17508145

Movement disorder due to aceruloplasminemia and incorrect diagnosis of hereditary hemochromatosis.

Alfonso Fasano, Anna Rita Bentivoglio, Cesare Colosimo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17508145     DOI： 10.1007/s00415-006-0289-6

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  12 in total

1.  Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence.

Authors:  J M Graham; M N Paley; R A Grünewald; N Hoggard; P D Griffiths
Journal:  Brain       Date:  2000-12       Impact factor: 13.501

2.  Karak syndrome: a novel degenerative disorder of the basal ganglia and cerebellum.

Authors:  A Mubaidin; E Roberts; D Hampshire; M Dehyyat; A Shurbaji; M Mubaidien; A Jamil; A Al-Din; A Kurdi; C G Woods
Journal:  J Med Genet       Date:  2003-07       Impact factor: 6.318

3.  Restless legs syndrome and low brain iron levels in patients with haemochromatosis.

Authors:  J Haba-Rubio; L Staner; C Petiau; G Erb; T Schunck; J P Macher
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07       Impact factor: 10.154

4.  Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease.

Authors:  A R Curtis; C Fey; C M Morris; L A Bindoff; P G Ince; P F Chinnery; A Coulthard; M J Jackson; A P Jackson; D P McHale; D Hay; W A Barker; A F Markham; D Bates; A Curtis; J Burn
Journal:  Nat Genet       Date:  2001-08       Impact factor: 38.330

5.  A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans.

Authors:  K Yoshida; K Furihata; S Takeda; A Nakamura; K Yamamoto; H Morita; S Hiyamuta; S Ikeda; N Shimizu; N Yanagisawa
Journal:  Nat Genet       Date:  1995-03       Impact factor: 38.330

6.  The basal ganglia in haemochromatosis.

Authors:  D Berg; U Hoggenmüller; E Hofmann; R Fischer; M Kraus; M Scheurlen; G Becker
Journal:  Neuroradiology       Date:  2000-01       Impact factor: 2.804

Review 7.  Wilson disease.

Authors:  Reinhard Kitzberger; Christian Madl; Peter Ferenci
Journal:  Metab Brain Dis       Date:  2005-12       Impact factor: 3.584

8.  [Extrapyramidal syndrome in idiopathic hemochromatosis. Significance of laboratory chemical, neurophysiologic and imaging procedures (CCT, MRT)].

Authors:  J Schröder; J Haan
Journal:  Nervenarzt       Date:  1987-09       Impact factor: 1.214

9.  Concurrent hereditary haemochromatosis and idiopathic Parkinson's disease: a case report series.

Authors:  D J Costello; S L Walsh; H J Harrington; C H Walsh
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-04       Impact factor: 10.154

10.  Hereditary haemochromatosis: a case of iron accumulation in the basal ganglia associated with a parkinsonian syndrome.

Authors:  J E Nielsen; L N Jensen; K Krabbe
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-09       Impact factor: 10.154
View more
  2 in total

1.  Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia.

Authors:  Alan Zanardi; Antonio Conti; Marco Cremonesi; Patrizia D'Adamo; Enrica Gilberti; Pietro Apostoli; Carlo Vittorio Cannistraci; Alberto Piperno; Samuel David; Massimo Alessio
Journal:  EMBO Mol Med       Date:  2018-01       Impact factor: 12.137

Review 2.  Disorders of metal metabolism.

Authors:  Carlos R Ferreira; William A Gahl
Journal:  Transl Sci Rare Dis       Date:  2017-12-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.